Clinical Trials Logo

Colon Cancer Liver Metastasis clinical trials

View clinical trials related to Colon Cancer Liver Metastasis.

Filter by:
  • Active, not recruiting  
  • Page 1

NCT ID: NCT03310008 Active, not recruiting - Clinical trials for Colon Cancer Liver Metastasis

Dose Escalation and Dose Expansion Phase I Study to Assess the Safety and Clinical Activity of Multiple Doses of NKR-2 Administered Concurrently With FOLFOX in Colorectal Cancer With Potentially Resectable Liver Metastases

SHRINK
Start date: August 7, 2017
Phase: Phase 1
Study type: Interventional

SHRINK (Standard cHemotherapy Regimen and Immunotherapy with NKR-2) is an open-label Phase I study to assess the safety and clinical activity of multiple administrations of autologous NKR-2 cells administered concurrently with a standard chemotherapy treatment (FOLFOX) in potentially resectable liver metastases from colorectal cancer. The trial will test three dose levels. At each dose, the patients will receive three successive administrations, two weeks apart, NKR-2 cells. The study will enroll up to 36 patients (dose escalation and expansion phases).